Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspective

Circulation. 2011 Jun 14;123(23):2664-5. doi: 10.1161/CIRCULATIONAHA.111.032433.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anticoagulants / adverse effects*
  • Consensus
  • Drug Labeling / standards*
  • Hemorrhage / chemically induced
  • Hemorrhage / epidemiology
  • Hemorrhage / prevention & control*
  • Humans
  • Platelet Aggregation Inhibitors / adverse effects*
  • Risk Factors
  • United States
  • United States Food and Drug Administration*

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors